Table of Contents Table of Contents
Previous Page  230 / 330 Next Page
Information
Show Menu
Previous Page 230 / 330 Next Page
Page Background

230

28

TH

CONGRESS OF THE ESPU

S20-11 (P without presentation)

DOES BMI INFLUENCE THE EFFICACY OF TENS

TREATMENT FOR OVERACTIVE BLADDER IN CHILDREN?

Raheej KHAN

1

, Massimo GARRIBOLI

2

, Joanna CLOTHIER

1

and Anne WRIGHT

1

1) Evelina London Children’s Hospital, Paediatric Nephro-Urology and Bladder Service, London, UNITED KINGDOM

- 2) Evelina London Children’s Hospital - Guy’s and St Thomas NHS Foundation Trust, Paediatric Urology, London,

UNITED KINGDOM

PURPOSE

Day and night-time urinary incontinence secondary to overactive bladder (OAB) is a disorder

frequently observed in children. Current therapies include urotherapy and anti-muscarinic drugs,

however both have shown poor outcomes. Recently, transcutaneous electric nerve stimulation

(TENS) has been demonstrated successful treatment for OAB. We aimed to assess compliance

and success of TENS in our population

MATERIAL AND METHODS

We randomly selected a cohort of patients from our prospectively maintained database. Patients

were prescribed TENS treatment for a maximum of 84 days. A bladder-voiding diary was completed

by parents. Patients were followed-up 3 months after the initiation of treatment. Demographic data

including age, gender and BMI were collected. Outcome parameters included: resolution of symp-

toms, length of treatment and compliance. We analysed results dividing patients based on compli-

ance (table 2) and BMI (table 3: Underweight (BMI<18.5), normal (18.5< BMI < 25), Overweight

(BMI > 25)).

RESULTS

Total

n=124

Females

n=72(58%)

Males

n=52(42%)

Median age

10(5-17)

11(5-17)

10(5-15)

Compliance

105(85%)

63(88%)

42(81%)

Median Days used/84 78(5-84)

78(5-84)

78(11-84)

No response

64(52%)

33(46%)

31(60%)

Partial/complete response 60(48%)

39(54%)

21(40%)

Total

N=124

Under weight

n=68(54%)

Normal

n=41(33%)

Over weight

n=15(13%)

p

No response

64(52%)

35(54%)

18(44%)

11(73%)

Partial/complete response 60(48%)

33(46%)

23(56%)

4(27%)

0.1

Total

n=124

Poor compliance

n=19

Good compliance

n=105

p

No response

64(51%)

10(53%)

54(51%)

Partial/complete response 60(49%)

9(47%)

51(49%)

0.95

CONCLUSIONS

Partial/complete response was obtained in half of the patients in the analysed cohort. Compliance

was high (85%). Nor BMI or compliance significantly influenced the success of the treatment.